Therapeutic Inertia in Prescribing Biologics for Patients with Moderate-to-Severe Asthma: Workshop Summary

Moderate-to-severe asthma represents about a quarter of the nearly 10% of Americans diagnosed with asthma. Many patients with moderate-to-severe asthma have uncontrolled symptoms that lead to exacerbations requiring oral corticosteroids. There are many factors contributing to poor asthma control, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sico, Isabelle P, Oberle, Amber, Thomas, Sheila M, Barsanti, Thomas, Egbuonu-Davis, Lisa, Kennedy, Daniel T, Zullig, Leah L, Bosworth, Hayden B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039536/
https://www.ncbi.nlm.nih.gov/pubmed/33854304
http://dx.doi.org/10.2147/PPA.S303841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039536/
https://www.ncbi.nlm.nih.gov/pubmed/33854304
http://dx.doi.org/10.2147/PPA.S303841

Ejemplares similares